中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/04/17 | 3,322 | 3,339 | 3,307 | 3,318 | -23 | -0.7% | 1,521,400 |
| 2023/04/14 | 3,325 | 3,341 | 3,305 | 3,341 | +29 | +0.9% | 2,986,900 |
| 2023/04/13 | 3,277 | 3,312 | 3,265 | 3,312 | +62 | +1.9% | 2,426,000 |
| 2023/04/12 | 3,262 | 3,279 | 3,248 | 3,250 | +5 | +0.2% | 1,495,100 |
| 2023/04/11 | 3,235 | 3,282 | 3,228 | 3,245 | +10 | +0.3% | 2,530,600 |
| 2023/04/10 | 3,235 | 3,256 | 3,230 | 3,235 | +8 | +0.2% | 1,520,800 |
| 2023/04/07 | 3,231 | 3,231 | 3,208 | 3,227 | +4 | +0.1% | 1,619,700 |
| 2023/04/06 | 3,222 | 3,234 | 3,203 | 3,223 | -15 | -0.5% | 3,283,700 |
| 2023/04/05 | 3,319 | 3,325 | 3,238 | 3,238 | -81 | -2.4% | 2,345,100 |
| 2023/04/04 | 3,285 | 3,349 | 3,276 | 3,319 | +69 | +2.1% | 2,729,500 |
| 2023/04/03 | 3,279 | 3,294 | 3,243 | 3,250 | -20 | -0.6% | 1,812,800 |
| 2023/03/31 | 3,251 | 3,275 | 3,227 | 3,270 | +27 | +0.8% | 3,122,200 |
| 2023/03/30 | 3,282 | 3,287 | 3,225 | 3,243 | -39 | -1.2% | 1,947,600 |
| 2023/03/29 | 3,253 | 3,284 | 3,230 | 3,282 | +14 | +0.4% | 2,071,500 |
| 2023/03/28 | 3,281 | 3,292 | 3,253 | 3,268 | -3 | -0.1% | 1,689,900 |
| 2023/03/27 | 3,215 | 3,280 | 3,212 | 3,271 | +51 | +1.6% | 1,864,100 |
| 2023/03/24 | 3,230 | 3,232 | 3,209 | 3,220 | -35 | -1.1% | 1,728,100 |
| 2023/03/23 | 3,288 | 3,294 | 3,246 | 3,255 | -69 | -2.1% | 1,811,500 |
| 2023/03/22 | 3,339 | 3,378 | 3,318 | 3,324 | +13 | +0.4% | 2,293,900 |
| 2023/03/20 | 3,376 | 3,392 | 3,311 | 3,311 | -55 | -1.6% | 2,001,800 |
| 2023/03/17 | 3,343 | 3,372 | 3,335 | 3,366 | +34 | +1% | 3,239,700 |
| 2023/03/16 | 3,280 | 3,332 | 3,267 | 3,332 | +28 | +0.8% | 2,321,900 |
| 2023/03/15 | 3,304 | 3,315 | 3,285 | 3,304 | -2 | -0.1% | 2,297,400 |
| 2023/03/14 | 3,285 | 3,320 | 3,263 | 3,306 | -22 | -0.7% | 2,345,900 |
| 2023/03/13 | 3,331 | 3,348 | 3,308 | 3,328 | -16 | -0.5% | 1,609,000 |
| 2023/03/10 | 3,397 | 3,398 | 3,331 | 3,344 | -53 | -1.6% | 3,659,500 |
| 2023/03/09 | 3,378 | 3,405 | 3,377 | 3,397 | +12 | +0.4% | 1,623,700 |
| 2023/03/08 | 3,365 | 3,385 | 3,362 | 3,385 | +1 | ±0% | 1,628,900 |
| 2023/03/07 | 3,367 | 3,398 | 3,364 | 3,384 | +3 | +0.1% | 1,646,400 |
| 2023/03/06 | 3,410 | 3,417 | 3,381 | 3,381 | -15 | -0.4% | 1,596,600 |
| 2023/03/03 | 3,342 | 3,406 | 3,315 | 3,396 | +81 | +2.4% | 2,724,100 |
| 2023/03/02 | 3,323 | 3,333 | 3,298 | 3,315 | -8 | -0.2% | 2,397,300 |
| 2023/03/01 | 3,342 | 3,366 | 3,318 | 3,323 | -71 | -2.1% | 2,512,500 |
| 2023/02/28 | 3,430 | 3,442 | 3,381 | 3,394 | -31 | -0.9% | 3,738,400 |
| 2023/02/27 | 3,451 | 3,465 | 3,417 | 3,425 | -62 | -1.8% | 1,642,300 |
| 2023/02/24 | 3,529 | 3,529 | 3,436 | 3,487 | -47 | -1.3% | 2,137,900 |
| 2023/02/22 | 3,528 | 3,566 | 3,513 | 3,534 | -28 | -0.8% | 2,259,900 |
| 2023/02/21 | 3,544 | 3,580 | 3,543 | 3,562 | -8 | -0.2% | 1,557,900 |
| 2023/02/20 | 3,560 | 3,588 | 3,542 | 3,570 | +14 | +0.4% | 1,612,600 |
| 2023/02/17 | 3,573 | 3,584 | 3,543 | 3,556 | -16 | -0.4% | 2,102,800 |
| 2023/02/16 | 3,586 | 3,594 | 3,551 | 3,572 | -14 | -0.4% | 2,054,100 |
| 2023/02/15 | 3,636 | 3,639 | 3,567 | 3,586 | -33 | -0.9% | 3,282,700 |
| 2023/02/14 | 3,613 | 3,629 | 3,605 | 3,619 | +45 | +1.3% | 1,893,900 |
| 2023/02/13 | 3,573 | 3,604 | 3,553 | 3,574 | -25 | -0.7% | 2,030,000 |
| 2023/02/10 | 3,600 | 3,615 | 3,557 | 3,599 | +71 | +2% | 5,584,800 |
| 2023/02/09 | 3,440 | 3,528 | 3,436 | 3,528 | +50 | +1.4% | 2,950,800 |
| 2023/02/08 | 3,465 | 3,489 | 3,454 | 3,478 | +52 | +1.5% | 2,806,100 |
| 2023/02/07 | 3,399 | 3,451 | 3,392 | 3,426 | +26 | +0.8% | 2,229,100 |
| 2023/02/06 | 3,391 | 3,414 | 3,367 | 3,400 | +23 | +0.7% | 2,536,900 |
| 2023/02/03 | 3,296 | 3,428 | 3,271 | 3,377 | +81 | +2.5% | 3,456,800 |
501～
550
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 862,000円 | +1.7% | +5.0% | 2.90% | 34.60倍 | 7.46倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
